VTRS FY 2024 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$17B

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$14.7B-4.5% YoY

Gross Profit

$5.6B38.2% margin

Operating Income

$10M0.1% margin

Net Income

-$634M-4.3% margin

EPS (Diluted)

$-0.53

Cash Flow

Operating Cash Flow

$2.3B

Free Cash Flow

$2.0B

Stock-Based Comp.

$146M

Balance Sheet

Total Assets

$41.5B

Total Liabilities

$22.9B

Stockholders' Equity

$18.6B

Cash & Equivalents

$735M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14.7B	$15.4B	-4.5%
Gross Profit	$5.6B	$6.4B	-12.7%
Operating Income	$10M	$766M	-98.7%
Net Income	-$634M	$55M	-1259.4%